Gender and racial bias in drug promotional material distributed by pharmaceutical companies
- 1*,
- 1,
- 1,
- 2
- 1Departments of Pharmacology, College, Surat, India.
- 2Community Medicine, Govt. Medical College, Surat, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Jaykaran
Departments of Pharmacology, College, Surat, India.
Email: drjaykaran@yahoo.co.in
Copyright: © 2012 The Author(s). This is an open access article.
Abstract
Pharmaceutical industries promote their drugs with the intention to influence the prescription decision of health care provider / physicians and adopt various methods like distribution drug promotional materials to the health care provider, publishing drug advertisements in medical journals, personal visits to the health care provider/physicians by designated representatives and sponsoring conferences/CMEs (continuous medical education). Sometime this may influence the health care provider/physician and may lead to the wrong or inappropriate choice of medications, which is an issue of immense ethical concern and also can compromise with the treatment protocol. Quality of these promotional materials are always under scanner and many studies done for drug advertisements published in Indian and western journals show that many of the advertisements provides insufficient, incorrect and biased information.[1-3] One major issue that emerged was biased nature of pictures and images in drug promotional materials distributed to physicians in hospitals and clinics. In a study done by Hawkins et al., it was observed that most of the doctors shown in advertisements were men and most of the consumers were women. Men were more often shown as worker and when women were showing working, it was usually feminine jobs like waitress and secretaries.[4] Ideally drug advertisements should have pictures according to racial and ethnic composition of people of that country, should have equal numbers of male and females, and females should be portrayed in similar ways as male.[5] There is scarcity of similar documentation to establish if such biases on drug promotional material distributed by pharmaceutical companies do occur in India. Present study is designed with the an overall aim of appraising the drug promotional materials distributed by pharmaceutical companies, to document presence of racial and gender bias, if any.
Keywords
Subject
Recommended articles
- Antidiabetic activity of stem bark of Bauhinia variegata in alloxan-induced hyperglycemic rats
Parveen Kumar, Shailesh Baraiya, S. N. Gaidhani · Journal of Pharmacology and Pharmacotherapeutics
- Hepatoprotective activity of active fractions of Thespesia lampas Dalz and Gibs (Malvaceae)
S. Stephen Ambrose, P. Solairaj, A. Subramoniam · Journal of Pharmacology and Pharmacotherapeutics
- Platelet aggregation inducing activity of Ficus racemosa stem bark extracts
Faiyaz Ahmed, Kumar S., Asna Urooj · Journal of Pharmacology and Pharmacotherapeutics
- Effect of rifampicin and erythromycin on the initiation of galactose induced cataract in rats
Raj Rajeshwari R. Patil, Pratibha S. Worlikar, Amol B. Chaudhari · Journal of Pharmacology and Pharmacotherapeutics
- Reporting of adverse drug reactions in clinical trials published in Indian Medical/Dental journals
Purav Mody, Tamoghona Biswas, Jaykaran Charan · Journal of Pharmacology and Pharmacotherapeutics
- A prescription survey in diabetes assessing metformin use in a tertiary care hospital in Eastern India
Manab Nandy, Ananya Mandal, Samar Banerjee · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and its Mutated Variants: Challenges and Future Directions
Mohammed Ali Bakkari, Gassem Ghoal, Fahad Y. Sabei
Jan 1, 2025
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026